メタドン

メタドン 化学構造式
76-99-3
CAS番号.
76-99-3
化学名:
メタドン
别名:
メタドン;rac-(R*)-6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン;6-ジメチルアミノ-4,4-ジフェニルヘプタン-3-オン;ヘプタドン;4,4-ジフェニル-6-(ジメチルアミノ)-3-ヘプタノン;ジアミノン;ドロフィン;(±)-メタドン;アミドン;メサドン;アルゴベチン;ヘプタノン(薬物);フィセプトン;rac-(6R*)-6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン;6-(ジメチルアミノ)-4,4-ジフェニル-3-ヘプタノン;ケタルギン;フェナドン;6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン;6-(ジメチルアミノ)-4,4-ジフェニルヘプタン-3-オン;4,4-ジフェニル-6-(ジメチルアミノ)ヘプタン-3-オン
英語名:
(+/-)-METHADONE
英語别名:
k174;Adanon;Amidone;Mecodin;Eptadone;Diaminon;Dolophin;Heptanon;Ketalgin;Methadon
CBNumber:
CB9707025
化学式:
C21H27NO
分子量:
309.45
MOL File:
76-99-3.mol

メタドン 物理性質

融点 :
78°
沸点 :
449.71°C (rough estimate)
比重(密度) :
1.0350 (rough estimate)
屈折率 :
1.5614 (estimate)
闪点 :
9℃
貯蔵温度 :
−20°C
酸解離定数(Pka):
pKa 8.25 (Uncertain)
EPAの化学物質情報:
3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- (76-99-3)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  F,T
Rフレーズ  11-23/24/25-39/23/24/25
Sフレーズ  7-16-36/37-45
RIDADR  UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany  1
有毒物質データの 76-99-3(Hazardous Substances Data)
毒性 LD50 oral in rat: 86mg/kg
絵表示(GHS) GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
注意喚起語 危険
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H225 引火性の高い液体および蒸気 引火性液体 2 危険 GHS hazard pictograms P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
H370 臓器の障害 特定標的臓器有害性、単回暴露 1 危険 GHS hazard pictograms P260, P264, P270, P307+P311, P321,P405, P501
注意書き
P210 熱/火花/裸火/高温のもののような着火源から遠ざ けること。-禁煙。
P260 粉じん/煙/ガス/ミスト/蒸気/スプレーを吸入しないこ と。
P280 保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。
P301+P310 飲み込んだ場合:直ちに医師に連絡すること。
P311 医師に連絡すること。

メタドン 化学特性,用途語,生産方法

効能

麻薬性鎮痛薬, オピオイド受容体作動薬, NMDA受容体拮抗薬

使用

Analgesic (narcotic).

定義

ChEBI: A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.

生物学の機能

Methadone (Dolophine) has an analgesic profile and potency similar to that of morphine but a longer duration of action and better oral bioavailability.The kinetic properties of methadone and its derivative, LAAM, have been shown to be useful in the treatment of opioid addiction. Methadone is a useful analgesic drug for the treatment of moderate to severe pain. Unlike morphine, it is generally not used epidurally because of its long duration of action. It is also rarely or never used in PCA systems or in pregnant women during labor. The side effects and signs of overdose following methadone administration are similar to those observed with morphine. Overdose is treated with naloxone. Clearance of methadone is via the urine and bile as the cyclic Ndemethylated drug. The ability to N-demethylate the drug decreases in elderly patients, prolonging the action of methadone. In such patients, dosing intervals should be longer than in younger patients. In addition, the pH of the urine has a major effect on clearance of the drug. Alkalinization of the urine or renal insufficiency decreases excretion of the drug.
Drug interactions and precautions for the use of methadone are similar to those of morphine. In addition, rifampicin and hydantoins markedly increase the metabolism of methadone and can precipitate withdrawal from methadone. Conversely, the tricyclic antidepressants and certain benzodiazepines can inhibit metabolism of methadone, thereby increasing accumulation of the drug, prolonging its half-life, and intensifying its side effects. Continuous dosing with methadone may lead to drug accumulation and to an increased incidence of side effects; methadone is generally not used for PCA. In pregnant heroin-addicted women, substitution of methadone for heroin has been shown to be associated with fewer low-birth-weight newborns and fewer learning and cognition problems later in the life of the child.

一般的な説明

Methadone (Dolophine) is a synthetic opioid approved for analgesic therapy and for the maintenance and treatment of opioid addiction. Methadone is marketed as the racemate, although the opioid activity resides in the R-enantiomer (7–50 times more potent than the S-enantiomer). Methadone may only be dispensed for the treatment of opioid addiction by a program certified by the Federal Substance Abuse and Mental Health Services Administration.
Methadone is a μ-receptor agonist with complex and highly variable pharmacokinetic parameters. The major metabolic pathway of methadone metabolism is via Ndemethylation to an unstable product that spontaneously cyclizes to form the inactive 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine (EDDP).

薬理学

Methadone is a diphenylpropylamine. It has very good oral bioavailability (~85%) with an oral to parenteral ratio of 1:2. Its plasma half-life can be highly variable (3–50h, average 24h) but its duration of action is relatively short. With repeated dosing, problems with accumulation can occur because of this discrepancy between half-life and analgesic effect. Careful monitoring is therefore required when converting patients to long-term methadone. A lso, there is incomplete cross-tolerance with morphine. The racemic mixture in common use has agonist actions at the MOP receptor (mainly the laevo isomer) as well as antagonist activity at the NMDA receptor dextro isomer). Given the importance of this receptor in central sensitisation in a variety of pain states, there may be cases where methadone offers particular advantages over and above other opioids (e.g. neuropathic pain). Plasma concentrations of methadone can be reduced by carbamazepine, and its metabolism is accelerated by phenytoin.

安全性プロファイル

Poison by ingestion, intraperitoneal, intravenous, subcutaneous, and intraduodenal routes. Human systemic effects: coma, nausea or vomiting, respiratory changes, respiratory depression, somnolence. An experimental teratogen. Experimental reproductive effects. Caution: Abuse leads to habituation or addiction. When heated to decomposition it emits toxic fumes of NOx. See also METHADONE HYDROCHLORIDE.

メタドン 上流と下流の製品情報

原材料

準備製品

76-99-3(メタドン)キーワード:


  • 76-99-3
  • 6-Dimethyamino-4,4-diphenyl-heptan-3-one
  • DL-METHADONE
  • methadona
  • Methadone M
  • methadone(l)
  • methadonum(latin)
  • methadose
  • Phenadone
  • Physeptone
  • Polamidon
  • Polamidone
  • Racemic methadone
  • 6-dimethylamino-4,4-diphenylheptan-3-one
  • Methadone {D.D.}
  • Methaquaione
  • 1,1-Diphenyl-1-[2-dimethylaminopropyl]-2-butanone
  • (RS)-Methadone
  • Eptadone
  • rac Methadone
  • Sedo-Rapide
  • Methadone (base and/or unspecified salts)
  • DL-6-Dimethylamino4,4-diphenyl-3-heptanone solution
  • DL-Methadone solution
  • (±)-Methdone
  • Methanol(test(±)-Methadone 1.0 mg/mL)
  • (+/-) METHADONE (5 AMPS/PKGE)
  • (±)-Methadone solution
  • 2-Dimethylamino-4,4-diphenyl-5-heptanone
  • 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-
  • 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, (±
  • メタドン
  • rac-(R*)-6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン
  • 6-ジメチルアミノ-4,4-ジフェニルヘプタン-3-オン
  • ヘプタドン
  • 4,4-ジフェニル-6-(ジメチルアミノ)-3-ヘプタノン
  • ジアミノン
  • ドロフィン
  • (±)-メタドン
  • アミドン
  • メサドン
  • アルゴベチン
  • ヘプタノン(薬物)
  • フィセプトン
  • rac-(6R*)-6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン
  • 6-(ジメチルアミノ)-4,4-ジフェニル-3-ヘプタノン
  • ケタルギン
  • フェナドン
  • 6-ジメチルアミノ-4,4-ジフェニル-3-ヘプタノン
  • 6-(ジメチルアミノ)-4,4-ジフェニルヘプタン-3-オン
  • 4,4-ジフェニル-6-(ジメチルアミノ)ヘプタン-3-オン
  • 麻薬性鎮痛薬
Copyright 2017 © ChemicalBook. All rights reserved